cordato.com

What It Is

Cordato positions itself as “predictive healthcare infrastructure,” primarily serving Medicare Advantage, Medicaid, commercial MCOs, and value-based care providers. It connects continuous signals from wearables, remote monitoring, and connected devices—such as heart rate, sleep, body temperature, activity, and blood glucose—with medical claims and care workflows. The goal is to predict risks and trigger interventions before symptoms or high-cost events occur.

Core Capabilities

The platform claims to use personalized health models to generate daily risk predictions, anomaly detection, and intervention triggers, routing alerts into existing networks such as telehealth, pharmacies, clinics, and care management teams. Typical modules include predictive remote monitoring, population health analytics, clinical operations prioritization, and care team alerts. Its approach is patent-pending and involves digital biomarker extraction and individual baseline modeling, but the website does not disclose model architecture, training data, accuracy, external validation, or medical statistical methodology.

Pricing and Trial

The website does not publish pricing, nor does it clarify whether billing is based on member count, organization size, or project scope. One relatively useful offering is its “no-cost retrospective simulation”: customers provide historical claims and available biosignals, and Cordato reports which ER visits, hospitalizations, or deterioration events could have been predicted, the lead time, and estimated ROI. It also offers a 90-day pilot, emphasizing no long-term commitment and no need for full integration upfront.

Pros and Cons

Its strengths are a highly focused use case, designed around the issues payers care about most: total cost of care, readmissions, STARS/HEDIS quality measures, and allocation of care resources. Its deployment approach is also pragmatic, emphasizing that it can sit on top of existing EHR, claims, and care management systems. The downside is a lack of transparency around key information: pricing, contracts, API standards, device compatibility lists, and privacy terms are not fully disclosed; the Terms of Service page is still placeholder content. Case materials mention a 23% reduction in readmissions and sample prediction metrics, but do not provide sample sizes or control-study design.

Who It’s For and Access from China

Cordato is better suited to U.S. health insurance plans, risk-sharing medical groups, population health management teams, and healthcare economics teams. It is not a lightweight tool for individual patients or ordinary clinics. Access and payment information from China is unclear, and the site does not indicate Chinese-language support or China-specific compliance capabilities. If looking for alternatives in China, it would make more sense to compare local vendors in remote monitoring, chronic disease management, healthcare cost control, and hospital CDSS, rather than directly applying Cordato’s U.S. payer-oriented model.